Is Sino Biopharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Sino Biopharmaceutical pays dividends. Last time was Friday 4th of October 2024 where the investors holding the stock on Tuesday 10th of September 2024 were paid HKD0.03 per share. Over the last 72 times between 2004 and 2024, Sino Biopharmaceutical has paid HKD1.3633 with an average of HKD0.02 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Sino Biopharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD7.29, you would have made a loss of HKD-4.12 per share or -56.52%
Yes, the average daily trading liquidity for Sino Biopharmaceutical is HKD46.88 million. You should therefore be able to get in and out of your positions relatively fast.
Sino Biopharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.21, the company's ability to pay off the debt is normal. Sino Biopharmaceutical has a good net profit margin of 8.24% and should have high tolerances against inflation.
We have calculated the inflation risk for Sino Biopharmaceutical to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.